Download Brochure
To download the brochure please fill out the form below.
Luxora is InMode's advanced multi-technology facial workstation, bringing together a suite of clinically proven radiofrequency technologies into a single, intelligent platform, purpose-built for cosmetic physicians and facial plastic surgeons.
The platform combines radiofrequency-assisted lipolysis (RFAL), minimally invasive fractional RF, fractional RF microneedling, and non-invasive RF into one system, enabling practitioners to address a comprehensive range of facial soft tissue concerns, from skin laxity and facial contouring to tissue remodelling, within an in-office or surgical setting.
Luxora is designed to treat patients who are not ideal candidates for major facial surgery, as well as patients seeking non-surgical or minimally invasive alternatives. Suitability for treatment and the appropriate technology selection is assessed by the treating practitioner on an individual basis.
REFINED TECHNOLOGY.
By adding Luxora to your practice, you can offer a comprehensive facial treatment platform that supports a broad range of clinical presentations, from non-surgical facial rejuvenation to minimally invasive contouring, without the need for multiple standalone devices.
Dr. Alfredo Hoyos
Top 3 reasons to use QuantumRF
Dr. Jessica West
QuantumRF 10 clinical demonstration
Dr. Jonathan Loo
QuantumRF contraction in action
Dr. Erez Dayan
QuantumRF contraction in action
Luxora is InMode's advanced facial workstation, integrating six radiofrequency technologies - QuantumRF 10, AccuTite, FaceTite, FaceTite Turbo, Morpheus8 Burst (face applicator), and Forma - into a single, intelligent platform. It is designed for use by cosmetic physicians and facial plastic surgeons, and is indicated for dermatological and general surgical procedures requiring soft tissue contraction, and for procedures where haemostasis is needed.
Luxora is designed for use by cosmetic physicians and facial plastic surgeons. It is intended to support practitioners treating patients who are not ideal candidates for major excisional facial surgery, patients with facial laxity seeking a non-surgical or minimally invasive alternative, and patients with laxity in the early-to-moderate range who may not be appropriate for surgical facial procedures. Individual patient suitability is assessed by the treating practitioner.
Luxora includes: QuantumRF 10 (minimally invasive fractional RF for delicate facial zones); AccuTite (precision RFAL for the most delicate facial areas including periorbital and perioral); FaceTite (RFAL for the face and neck); FaceTite Turbo (enhanced RFAL with higher power output); Morpheus8 Burst with face applicator (fractional RF microneedling from 0.5 mm to 5 mm depth); and Forma (non-invasive RF for facial skin maintenance). These modalities may be used individually or in combination, based on the treating practitioner's clinical assessment.
Luxora is designed to address a range of facial and neck areas, including the periorbital region, temples, nasolabial folds, perioral area, jowls, lower face, jawline, and neck. The specific technology used and treatment area are determined by the treating practitioner based on individual patient assessment. All treatments must be performed within the practitioner's scope of practice.
Luxora technologies are indicated for dermatological and general surgical procedures requiring soft tissue contraction. AccuTite, FaceTite, and FaceTite Turbo are also indicated for procedures where haemostasis is needed. Treatments may be used to address facial skin laxity, soft tissue remodelling, and facial contouring concerns. Specific indications for each technology should be confirmed with the InMode Australia clinical team. All treatments must be performed within the practitioner's scope of practice.
Luxora uses bipolar radiofrequency (RF) energy delivered through multiple modalities to heat targeted facial tissue layers. Depending on the technology: AccuTite, FaceTite, and FaceTite Turbo deliver RFAL energy between an internal cannula and an external electrode, treating the subdermal and dermal layers simultaneously. QuantumRF 10 delivers fractional RF internally via a minimally invasive cannula to subdermal tissue. Morpheus8 Burst delivers fractional RF energy via microneedles to multiple depths from 0.5 mm to 5 mm. Forma delivers non-invasive RF energy to superficial skin layers. Built-in temperature and impedance feedback monitors tissue response and automatically adjusts energy delivery. Individual tissue response varies between patients.
Downtime varies depending on the specific technology used, treatment parameters, and the individual patient. RFAL treatments (AccuTite, FaceTite, FaceTite Turbo) are minimally invasive and associated with a short recovery period. Morpheus8 Burst is generally associated with a short downtime period. Forma is non-invasive and typically involves minimal to no downtime. Treating practitioners will advise on expected recovery and aftercare based on each patient's individual treatment plan.
No. Not all patients are appropriate candidates for Luxora treatments or all Luxora modalities. Individual suitability must be assessed by a qualified practitioner prior to treatment, taking into account the patient's medical history, skin condition, goals, and other clinical factors. Luxora is designed for use by qualified cosmetic physicians and facial plastic surgeons.
No. Treatment outcomes vary between individuals and depend on factors including patient anatomy, skin condition, treatment parameters, health status, and aftercare. Multiple sessions may be required depending on the treatment modality and clinical objectives. The treating practitioner will discuss expected outcomes, number of sessions, and limitations as part of the individual patient consultation.
Luxora technologies are supplied in Australia as therapeutic goods. Specific ARTG inclusion details for each individual Luxora component can be confirmed with the InMode Australia clinical and regulatory team. All devices are used in accordance with applicable Australian regulatory requirements.
Luxora is designed for: dedicated cosmetic physician practices, facial plastic surgery clinics, and aesthetic medical practices led by cosmetic physicians or facial plastic surgeons. All practitioners must be appropriately credentialled and trained to use the specific technologies within Luxora within their scope of practice.
All Luxora users must be appropriately trained and work within their scope of practice and relevant credentialling requirements. InMode Australia provides device training and clinical education to support safe and effective use, in line with professional guidelines, AHPRA requirements, and TGA regulations. Contact the InMode Australia team to discuss training pathways for your practice.
InMode Australia provides: comprehensive device and clinical training; local technical and service support; ongoing clinical education; and access to InMode's resource library. Contact the InMode Australia team to discuss support options for your practice.
